Celgene Corp De, Ten Percent Owner at Adynxx, holds 7.01M shares in Acceleron Pharma (Ticker: XLRN), holds 7.12M shares in Agios Pharma (Ticker: AGIO), holds 1.73M shares in Sutro Biopharma (Ticker: STRO). Most recently, Celgene Corp De Sold ― shares of Acceleron Pharma on Jul 13, 2020 for an estimated value of 229.21K.
What is the percentage of profitable transactions made by Celgene Corp De?
The percentage of profitable transactions made by Celgene Corp De is 29%.
What is the average return per transaction made by Celgene Corp De?
The average return per transaction made by Celgene Corp De is -15.20%.
What stocks does Celgene Corp De hold?
Celgene Corp De holds: ADYX, CRSP, AGIO, STRO, RCPT, XLRN, CASI stocks.
What was Celgene Corp De’s latest transaction?
Celgene Corp De latest transaction was an Informative Sell of $229.21K.
What was Celgene Corp De's most profitable transaction?
Celgene Corp De’s most profitable transaction was an Informative Buy of XLRN stock on September 25, 2017. The return on the trade was 67.00%.
What is Celgene Corp De's role in Adynxx?
Celgene Corp De's role in Adynxx is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.